• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Attendees gather outside hours before Charlie Kirk’s memorial begins

admin - Latest News - September 21, 2025
admin
38 views 2 mins 0 Comments


IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    Attendees gather outside hours before Charlie Kirk’s memorial begins

    00:54

  • UP NEXT

    Armed man charged with allegedly posing as law enforcement at Charlie Kirk memorial site

    00:42

  • Protesters hit with tear gas outside Illinois ICE facility

    00:55

  • Gen Z choosing trade schools over college

    04:04

  • Texas A&M president resigns over viral video on gender-identity lesson

    02:09

  • Grammy-winning songwriter Brett James killed in plane crash

    01:29

  • Shooting at ABC station in Sacramento, with company facing criticism over Kimmel suspension

    02:55

  • CDC panel votes to change recommendations for Covid vaccines

    02:01

  • Researchers say support for political violence is growing, especially online

    02:19

  • Source: Former WH chief of staff testifies Biden’s memory declined in office

    01:35

  • Police respond to shots fired at ABC building in Sacramento, no one injured

    02:13

  • Forecasting the best fall foliage viewing days in New England

    02:41

  • CDC panel votes to change guidance on MMRV vaccine for kids

    04:27

  • Man dies from blunt impact injuries after going on Epic Universe theme park roller coaster

    01:46

  • FTC sues Live Nation and Ticketmaster over claims of illegal resale tactics

    02:09

  • Pepper spray used to stop fight at Florida high school sends 32 to hospital

    00:25

  • Brigitte Macron to show court ‘scientific proof’ she is a woman in lawsuit against Candace Owens

    02:42

  • PA authorities identify gunman in deadly shooting

    01:47

  • Hollywood rallies behind Kimmel, while Trump and supporters cheer suspension

    03:08

  • Mystery deepens around body of teen found in singer D4vd’s car

    01:35

Crowds began to gather hours before Charlie Kirk’s memorial was set to begin, with many lining up before sunrise, in the parking lots of State Farm Stadium.Sept. 21, 2025

  • Now Playing

    Attendees gather outside hours before Charlie Kirk’s memorial begins

    00:54

  • UP NEXT

    Armed man charged with allegedly posing as law enforcement at Charlie Kirk memorial site

    00:42

  • Protesters hit with tear gas outside Illinois ICE facility

    00:55

  • Gen Z choosing trade schools over college

    04:04

  • Texas A&M president resigns over viral video on gender-identity lesson

    02:09

  • Grammy-winning songwriter Brett James killed in plane crash

    01:29



Source link

TAGS:
PREVIOUS
Retired nuns on the run break back into convent
NEXT
Trump says the Murdochs will most likely have a role in the U.S. TikTok deal
Related Post
November 1, 2025
Serbia marks first anniversary of deadly roof collapse
September 27, 2025
Sept. 27, 2025, 5:30 AM EDTBy Berkeley Lovelace Jr.For people who rely on certain prescription drugs, including weight loss, asthma and cancer medications, President Donald Trump’s post announcing 100% tariffs on foreign brand-name drugs offers little clarity on when — or if — medications might see price hikes. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump said on Truth Social late Thursday. “‘IS BUILDING’ will be defined as, ‘breaking ground’ and/or ‘under construction.’ There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”Experts say Trump’s post raises a lot of questions. Here are five major ones. What drugs will be impacted?Trump’s post doesn’t specify whether brand-name drugmakers with an existing U.S. plant would be exempt, whether that exemption would include all their products, or whether it would only be for the drugs manufactured at the U.S. site. Novo Nordisk and Eli Lilly, makers of the weight loss drugs Wegovy and Zepound, respectively, have announced plans to invest in U.S. manufacturing. But it’s unclear if their intent to invest will warrant an exemption. On Tuesday, Lilly announced plans for a $6.5 billion manufacturing facility in Houston that will produce Zepbound and its other GLP-1 drug, Mounjaro, following a recent commitment to build a $5 billion plant near Richmond, Virginia. Novo Nordisk, a Danish company, said in June it would spend $4.1 billion to construct a second GLP-1 fill-finish plant in Clayton, North Carolina.AstraZeneca, which makes the asthma drug Symbicort, also announced in July that it will invest $50 billion over the next five years to expand its research and development and manufacturing footprint in the U.S. Many other popular brand-name drugs, however, are primarily manufactured overseas, particularly in Europe, said Rena Conti, an associate professor at Boston University’s Questrom School of Business.Botox, made by Allergen, and the cancer drug Keytruda from drugmaker Merck are made in Ireland. (Keytruda’s manufacturing has increasingly moved to the United States in recent years, but it’s not clear if that would earn an exemption from Trump’s tariffs.)Others, including some for blood and lung cancers, as well as vaccines, are made in places like India and China, Conti said. “I think what’s most at risk here are branded products that come from China and India,” she said. The E.U. and Japan already have trade agreements in place that cover pharmaceuticals, she added, and it’s unclear whether the new tariff will supersede that. Will patients see prices increase?Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are much cheaper and will not be affected by these tariffs. Whether patients see price increases will depend on how many drugmakers receive exemptions — and on whether companies choose to pass those costs on to patients at the pharmacy counter, said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. ​​“Ultimately, tariffs are taxes on patients,” Kesselheim said, “and to the extent that drug companies see increases in cost due to tariffs, they will pass those costs on to patients.”Some companies may decide not to pass the costs along. So far, the 15% tariffs on imports from the E.U. haven’t translated into big price hikes for U.S. patients, Conti noted. To be sure, a 100% tariff would be far more costly for a company. Price hikes may not start right away, as drugmakers find out whether they qualify for an exemption. There also might be a lag since U.S. law prevents drugmakers from increasing the price of drugs faster than inflation.“What if you’re doing updates to the plant you currently have? What if you’re planning a facility? Do those count?” Kesselheim said. “It’s all very ambiguous.”Some patients may not notice additional price hikes at all, given how costly brand-name drugs already are in the U.S., said Arthur Caplan, the head of the Division of Medical Ethics at NYU Langone Medical Center in New York City. “I can certainly predict that some patients will immediately feel price increases that will shock them on some of these drugs,” Caplan said.Could insurers absorb the costs?Insurers and middlemen, known as pharmacy benefit managers, could try to negotiate drugmakers or absorb some of the tariff-related costs, Caplan said.It’s more likely, however, that they’d pass it on to patients in the short term, potentially in the form of a larger copay, he said.It’s not only patients with private insurance that should be worried about price hikes, Kesselheim said. Those who get their drugs covered through government health programs could also see price increases.“The government is the largest purchaser of prescription drugs in the market, through Medicare, Medicaid and the VA, so it’s really the government or government payers that are going to see the largest impact on price increases,” he said. Will tariffs spur more U.S. drug manufacturing?It’s unlikely, Kesselheim said. The decision to build a plant “is a complicated and expensive one” that requires several regulatory hurdles and years of planning.Conti noted that by the time new manufacturing plants are completed, Trump would likely be out of office.“It is somewhere between two years and five years to get new production facilities built,” she said, “and it can be in the millions of dollars depending on whether the product that you’re making is a small molecule drug or a biologic.”Even putting money back into an existing plant isn’t quick.“If you want to switch a line or retool a factory to make a product, then we’re talking about somewhere between 18 to 36 months to do that,” Conti said, “because you have to show the U.S. regulator that you can make it at this factory at scale, and the product is what it says it is, or is high quality and meets the quality standards of the U.S.”In a statement, Alex Schriver, a spokesperson for the trade group the Pharmaceutical Research and Manufacturers of America, said “most innovative medicines prescribed in America are already made in America” and companies continue to invest in the U.S.“Tariffs risk those plans because every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Schriver said. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”What about shortages?If Trump keeps his focus solely on brand-name drugs, U.S. patients are unlikely to face shortages, Kesselheim said.“Their profits are just so, so far beyond this tariff cost that they could probably be OK or raise the prices of the drugs,” he said. “They would probably not stop production as a result.”But that excludes, he added, some smaller companies who may make niche brand-name products and may not have the resources to take on the extra costs. If tariffs extend to generics, the risk is far greater, Caplan added. Unlike brand-name drugs, generic drugs are typically sold at close to the cost they’re made, he said, which makes it difficult for companies to justify the cost of building a new facility. They’d likely be forced to walk away from production or close their plants altogether.Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
November 9, 2025
Nov. 9, 2025, 6:00 AM ESTBy Alexander SmithFears over dependency on Chinese technology have reached an unlikely corner of the West: the previously serene and efficient world of Scandinavian public transportation.European nations have become increasingly worried that their vast amounts of Chinese-built infrastructure could be weaponized — tampered with, immobilized or even commandeered — if tensions were to rise with Beijing. Now, bus providers in Denmark and Norway say they are urgently investigating and remedying what they say is a security loophole discovered in their fleets of vehicles made by Yutong, a company based in Zhengzhou, China, that is the world’s largest manufacturer of buses by sales volume.Because these buses can receive updates and diagnostic tests “over the air,” they can be “stopped remotely, either by the manufacturer or by a hacker,” Jeppe Gaard, chief operating officer of the Danish public transport provider Movia, told NBC News in an email Wednesday.“Electric buses, like electric cars, in principle can be remotely deactivated if their software systems have online access,” he said. This isn’t just a “Chinese bus concern; it is a challenge for all types of vehicles and devices with these kinds of electronics built in,” Gaard added.In Denmark, Movia’s fleet includes 262 Yutong buses, which have been phased in since 2019 across a network that covers the capital, Copenhagen, and the east of the country, Movia said.Trump reaches trade war truce with China01:49The alarm was first raised earlier this month by the Norwegian bus operator Ruter, which runs half of the country’s public transport, including in Oslo, the capital.Ruter performed underground tests “inside a mountain” on two buses: the Yutong model and one from the Dutch manufacturer VDL.While the Dutch buses “do not have the capability for autonomous software updates over the air,” Yutong “has direct digital access to each individual bus for software updates and diagnostics,” it said.In theory, “this bus can be stopped or rendered inoperable by the manufacturer,” it said, although Yutong wouldn’t be able to remotely drive these vehicles.Asked for comment on the Danish and Norwegian moves, Yutong sent an emailed statement saying that it “understands and highly values the public’s concerns regarding vehicle safety and data privacy protection,” and “strictly complies with the applicable laws, regulations, and industry standards.”It said its vehicle data in the European Union is stored in an Amazon Web Services data center in Frankfurt, Germany, where it is “protected by storage encryption and access control measures,” and that “without customer authorization, no one is allowed to access or operate the system.”China’s Ministry of Commerce did not immediately respond to a request for comment.This is just the latest episode in Europe’s complex relationship with China: deeply reliant on Beijing’s trade and increasing know-how, but critical of its alleged cyber-aggression, rampant intellectual property theft and human rights violations.Even as hope rises for a new trade agreement between China and the E.U., there are grave concerns over plans for a new mega-embassy in London and a lingering scandal over the collapse of an alleged spying case at the heart of Westminster.Meanwhile, the Dutch government has seized control of the Chinese chipmaker Nexperia, in a saga that has raised fears that car production could come to a halt on the Continent.Even more so than the United States, European nations have relied on China for critical infrastructure — only to conclude that it poses a problem if and when relations go south.A number of European governments have torn out 5G networks made by the Chinese giants Huawei and ZTE — under pressure from Washington — because of fears they could be used by Beijing to compromise Western national security.Today’s hot-button issue is Chinese electric vehicles, which are effectively blocked from sale in the U.S. but whose market share is ballooning in Europe, doubling to 5.1% in the first half of 2025 from last year, according to the auto consultancy JATO Dynamics.As with other Western concerns, China has roundly rejected that its EVs and other technologies present a security risk.In January, China’s Foreign Ministry condemned American moves to block Chinese tech from the U.S. auto market, accusing it of “overstretching the concept of national security” and calling for Washington to “stop going after Chinese companies,” spokesman Guo Jiakun said at a daily news briefing. But plenty of security and intelligence officials are concerned.Western nations had “the whole problem with Huawei and 5G, and you’ve now got a similar problem in Chinese electric cars: that they can all be immobilized at a switch from the manufacturer,” the former head of Britain’s MI6 intelligence agency, Richard Dearlove, told NBC News in an interview earlier this year. “So if we have a crisis with China, they can bring London to a complete halt by reprogramming” these vehicles.In reality, this is also true of any electric vehicle — including those made by Tesla, for example — and many other items reliant on internet connectivity, said Ken Munro, founder of the British American cybersecurity consultancy Pen Test Partners.In Norway, Ruter, the electric bus operator, said it had carried out several fixes, including stricter controls on future bus purchases, “firewalls” to protect against hackers, and “collaborating with national and local authorities on clear cybersecurity requirements.”Are experts convinced this will work?“Not really,” Munro said.“Any degree of connectivity and the ability to update software, which we all want as consumers,” he said, “has to be enabled.” Munro added: “The only way to do this, to my mind, would be for the operator to remove all connectivity from that vehicle.”Munro questioned whether China would actually want to exploit a potential vulnerability like the one identified in the Scandinavian buses.“Do we believe that China would destroy its entire export industry for vehicles, EVs or not, in order to prove a political and military point? It is within the bounds of plausibility,” but the chances are “incredibly small,” Munro said.“It just comes down to trust,” he added. Alexander SmithAlexander Smith is a senior reporter for NBC News Digital based in London.Peter Guo contributed.
November 26, 2025
Inside the real town where 'Stranger Things' is filmed
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved